Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi bets on inhaled insulin with up to $925 mln MannKind deal
Sanofi bets on inhaled insulin with up to $925 mln MannKind deal
Sanofi bets on inhaled insulin with up to $925 mln MannKind deal
Submitted by
admin
on August 11, 2014 - 7:59am
Source:
Yahoo/Reuters
News Tags:
MannKind
Sanofi
diabetes
inhaled insulin
Afrezza
insulin
Headline:
Sanofi bets on inhaled insulin with up to $925 mln MannKind deal
Do Not Allow Advertisers to Use My Personal information
